Marrone Bio Innovations Inc
NASDAQ:MBII
Marrone Bio Innovations Inc
Operating Income
Marrone Bio Innovations Inc
Operating Income Peer Comparison
Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors
Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Marrone Bio Innovations Inc
NASDAQ:MBII
|
Operating Income
-$17.4m
|
CAGR 3-Years
1%
|
CAGR 5-Years
5%
|
CAGR 10-Years
N/A
|
|
CF Industries Holdings Inc
NYSE:CF
|
Operating Income
$2.3B
|
CAGR 3-Years
53%
|
CAGR 5-Years
26%
|
CAGR 10-Years
-1%
|
|
FMC Corp
NYSE:FMC
|
Operating Income
$692.2m
|
CAGR 3-Years
-13%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
0%
|
|
Corteva Inc
NYSE:CTVA
|
Operating Income
$1.9B
|
CAGR 3-Years
27%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Scotts Miracle-Gro Co
NYSE:SMG
|
Operating Income
$256.9m
|
CAGR 3-Years
-31%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
-4%
|
|
Mosaic Co
NYSE:MOS
|
Operating Income
$1.7B
|
CAGR 3-Years
36%
|
CAGR 5-Years
10%
|
CAGR 10-Years
1%
|
See Also
What is Marrone Bio Innovations Inc's Operating Income?
Operating Income
-17.4m
USD
Based on the financial report for Mar 31, 2022, Marrone Bio Innovations Inc's Operating Income amounts to -17.4m USD.
What is Marrone Bio Innovations Inc's Operating Income growth rate?
Operating Income CAGR 5Y
5%
Over the last year, the Operating Income growth was -19%. The average annual Operating Income growth rates for Marrone Bio Innovations Inc have been 1% over the past three years , 5% over the past five years .